See also this year's filing and all EDGAR filings for this company.
PDF Report 0001759425_2023_Mirum_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001759425, Mirum Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 190,225,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 58,954,000 |
| 2 | PropertyPlantAndEquipmentNet | 914,000 |
| 3 | remainder_Assets | 102,813,000 |
| 4 | LiabilitiesCurrent | 64,729,000 |
| 5 | LiabilitiesNoncurrent | 5,789,000 |
| 6 | remainder_Liabilities | 140,351,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 89,066,000 |
| 9 | ResearchAndDevelopmentExpense | 106,842,000 |
| 10 | remainder_Expenses | 21,041,000 |
| 11 | remainder_Revenues | 77,062,000 |
| 12 | remainder_NetIncome | 4,222,000 |
| 13 | remainder_ComprehensiveNetIncome | -182,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 352,906,000 |
| 1 | Liabilities | 210,869,000 |
| 2 | Expenses | 216,949,000 |
| 3 | Revenues | 77,062,000 |
| 4 | StockholdersEquity | 142,037,000 |
| 5 | NetIncome | -135,665,000 |
| 6 | ComprehensiveNetIncome | -135,756,000 |
| 7 | BaseVar | 431,095,000 |
| 8 | EconomicCapitalRatio | 0.385 |
Edgar->Model Mapping
Feature Distribution
Change over Time
